JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.14, sa.10, ss.1197-1203, 2020 (SCI-Expanded)
Introduction: Currently, several molecular assays are available to detect and quantify HBV DNA in clinical samples. We aimed to characterize and compare the clinical performance of newly designed NeuMoDx PCR to the existing artus PCR.